Noonan syndrome is a genetic disorder that affects multiple body systems, causing distinctive facial features, short stature, heart defects, and varying degrees of developmental differences. It occurs in roughly 1 in 1,000 to 2,500 live births, making it one of the more common genetic conditions. The severity ranges widely, from mild features that go unnoticed for years to significant health challenges identified at birth.
What Causes Noonan Syndrome
Noonan syndrome results from mutations in genes that control a specific cell-signaling pathway involved in growth and development. At least 12 different genes have been linked to the condition. The most commonly affected gene, PTPN11, accounts for about 50% of all cases. SOS1 mutations explain another 10% to 13%, and several other genes each contribute smaller percentages.
The condition follows an autosomal dominant inheritance pattern, meaning a child only needs one copy of the mutated gene (from one parent) to develop the syndrome. However, about 60% of cases arise from spontaneous new mutations rather than being passed down from a parent. If a parent does carry the gene, each pregnancy has a 50% chance of passing it on.
Facial and Physical Features
People with Noonan syndrome tend to share a recognizable set of facial characteristics, though these can become more or less noticeable with age. Common features include widely spaced eyes that are often pale blue or blue-green, low-set ears that are rotated backward, a deep groove between the nose and upper lip, a high-arched palate, a small lower jaw, and poor teeth alignment.
The neck is often short with extra skin folds (sometimes called webbing) and a low hairline at the back. Many individuals have chest wall differences: either a sunken chest (pectus excavatum) or a protruding chest (pectus carinatum). Scoliosis, a sideways curvature of the spine, also occurs in some cases.
Heart Defects
Heart problems are among the most significant health concerns in Noonan syndrome and affect the majority of individuals to some degree. The most common defect is pulmonary valve stenosis, a narrowing of the valve that controls blood flow from the heart to the lungs. One large study found pulmonary stenosis in 39% of patients, and it tends to be progressive, meaning it can worsen over time.
Other heart conditions linked to the syndrome include hypertrophic cardiomyopathy (thickening of the heart muscle), holes between the heart’s upper chambers, and more complex structural defects like tetralogy of Fallot. Because heart involvement is so common and variable, cardiac screening is a standard part of diagnosis and ongoing care.
Growth and Short Stature
Short stature is one of the hallmark features. Without treatment, average adult height reaches about 154 cm (roughly 5’1″) for women and 169 cm (about 5’7″) for men. Growth tends to follow a pattern of gradual falling behind, with puberty often delayed by a year or two, which further contributes to shorter stature during adolescence.
Growth hormone therapy is an approved treatment option. After four years of treatment, about 70% of children with Noonan syndrome reach a height within the normal range for their age and sex. Long-term data shows treated females gain an average of about 9 cm and treated males about 11 cm by age 18 compared to what would be expected without treatment. In one group followed into adulthood, 60% of treated patients reached heights of approximately 158 cm for women and 175 cm for men. Starting treatment earlier and continuing it for several years produces the best results.
Learning and Cognitive Development
Intelligence in Noonan syndrome spans a wide range, from intellectual disability to above-average scores. On average, children tend to score in the low-average range on standardized tests. Despite this modest average, nearly half of children with the condition need some form of special educational support, often due to specific difficulties rather than overall low ability.
The areas most commonly affected in childhood include visual processing, memory, language skills, attention, motor coordination, and executive functioning (the mental skills used for planning and organizing). The encouraging finding is that children with Noonan syndrome may outgrow many of these cognitive difficulties. Studies of adults with the condition show that most cognitive domains, including memory and executive functioning, perform within normal ranges. The main persistent difference in adults is a slower speed of processing information, though adults do tend to report more subjective cognitive complaints than people without the condition.
How It Is Diagnosed
Diagnosis typically involves two components: recognizing the characteristic physical features and confirming a gene mutation through genetic testing. A doctor may suspect Noonan syndrome based on a combination of facial features, heart defects, short stature, and chest wall abnormalities. Genetic testing then looks for mutations in the known associated genes. Because PTPN11 accounts for half of cases, it is usually tested first, followed by the less common genes if needed.
Some individuals with mild features are not diagnosed until childhood or even adulthood, particularly if heart involvement is minor. In other cases, heart defects detected before or shortly after birth prompt earlier genetic evaluation.
Ongoing Health Management
Because Noonan syndrome can affect so many body systems, care typically involves a team of specialists. Beyond cardiology and endocrinology (for growth), individuals may need monitoring for bleeding problems (many have clotting factor deficiencies or platelet dysfunction), kidney abnormalities, hearing issues, and lymphatic complications such as swelling in the limbs.
Regular cardiac follow-up is particularly important given that pulmonary valve stenosis can progress and cardiomyopathy may develop or change over time. Children benefit from developmental assessments to identify learning needs early, when intervention is most effective. Physical and occupational therapy can help with motor coordination challenges that are common in younger children.
Adult Life and Long-Term Outlook
Most people with Noonan syndrome live into adulthood and report a good quality of life on standard self-assessment measures. However, the condition does carry a higher mortality rate than the general population, with one study of 103 individuals finding the mortality ratio was three times the expected rate, partly driven by sudden cardiac events. This makes ongoing heart monitoring relevant throughout life, not just in childhood.
Adults with Noonan syndrome tend to have lower educational attainment compared to the general population and are more likely to live without a partner. These patterns likely reflect the combined effects of learning differences in childhood, shorter stature, and the social impact of managing a chronic condition. Still, many adults live independently and work in a range of occupations, particularly those who received early developmental support and consistent medical care.